Alto Neuroscience, Inc. Stock Issued During Period, Shares, New Issues
Alto Neuroscience, Inc. (ANRO) reported Stock Issued During Period, Shares, New Issues of 72.63 thousand shares for the 1-month period ending 2024-02-29, per its 10-Q filed 2025-05-14.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2025-11-12
- 2024-02-29: Stock Issued During Period, Shares, New Issues 1 month 72.63K shares.
- 2021-05-31: Stock Issued During Period, Shares, New Issues 1 month 72.63K shares.
| Period end | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|
| 2024-02-29 | 72.63K shares 10-Q · filed 2025-05-14 |
| 2021-05-31 | 72.63K shares 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |